Evidence for persistence of the SHIV reservoir early after MHC haploidentical hematopoietic stem cell transplantation

[1]  A. Reik,et al.  Differential impact of transplantation on peripheral and tissue-associated viral reservoirs: Implications for HIV gene therapy , 2018, PLoS pathogens.

[2]  N. Hamerschlak,et al.  Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation , 2018, Bone Marrow Transplantation.

[3]  Charles R. Thomas,et al.  Allogeneic stem cell transplantation in fully MHC-matched Mauritian cynomolgus macaques recapitulates diverse human clinical outcomes , 2017, Nature Communications.

[4]  J. Zaia,et al.  How I treat patients with HIV-related hematological malignancies using hematopoietic cell transplantation. , 2017, Blood.

[5]  J. Lifson,et al.  Defining total-body AIDS-virus burden with implications for curative strategies , 2017, Nature Medicine.

[6]  S. Furlan,et al.  Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant , 2017, Science Translational Medicine.

[7]  K. Reimann,et al.  Isolation of a monoclonal antibody from a phage display library binding the rhesus macaque MHC class I allomorph Mamu-A1*001 , 2017, PloS one.

[8]  Laila N. Abudulai,et al.  Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design , 2017, Front. Immunol..

[9]  A. Dickinson,et al.  Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia , 2017, Front. Immunol..

[10]  Nancie M Archin,et al.  Proviral Latency, Persistent Human Immunodeficiency Virus Infection, and the Development of Latency Reversing Agents. , 2017, The Journal of infectious diseases.

[11]  S. Furlan,et al.  The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  J. Brenchley,et al.  Tissue-resident macrophages can contain replication-competent virus in antiretroviral-naive, SIV-infected Asian macaques. , 2017, JCI insight.

[13]  R. Sékaly,et al.  Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation. , 2017, JCI insight.

[14]  M. Thakar,et al.  Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Children and Adolescents with Fanconi Anemia. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  S. Furlan,et al.  Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cells. , 2016, Blood.

[16]  A. Krishnan,et al.  Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial. , 2016, Blood.

[17]  G. Silvestri,et al.  Animal models to achieve an HIV cure , 2016, Current opinion in HIV and AIDS.

[18]  J. Lifson,et al.  Short Communication: Comparative Evaluation of Coformulated Injectable Combination Antiretroviral Therapy Regimens in Simian Immunodeficiency Virus-Infected Rhesus Macaques. , 2016, AIDS research and human retroviruses.

[19]  D. Kuritzkes.  Hematopoietic stem cell transplantation for HIV cure. , 2016, The Journal of clinical investigation.

[20]  B. Williamson,et al.  Higher Risk Myelodysplastic Syndromes in Patients with Well-Controlled HIV Infection: Clinical Features, Treatment, and Outcome , 2016, Case reports in hematology.

[21]  C. Ziegler,et al.  Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention , 2015, Science Translational Medicine.

[22]  Roger E Bumgarner,et al.  Lack of viral control and development of combination antiretroviral therapy escape mutations in macaques after bone marrow transplantation , 2015, AIDS.

[23]  U. Bayraktar,et al.  "No donor"? Consider a haploidentical transplant. , 2015, Blood reviews.

[24]  S. Esser,et al.  More on shift of HIV tropism in stem-cell transplantation with CCR5 delta32/delta32 mutation. , 2014, The New England journal of medicine.

[25]  Z. Klase,et al.  Tissue myeloid cells in SIV-infected primates acquire viral DNA through phagocytosis of infected T cells. , 2014, Immunity.

[26]  Emily B Hanhauser,et al.  Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation , 2014, Annals of Internal Medicine.

[27]  A. Rios.  HIV-related hematological malignancies: a concise review. , 2014, Clinical lymphoma, myeloma & leukemia.

[28]  G. Silvestri,et al.  Persistence of Virus Reservoirs in ART-Treated SHIV-Infected Rhesus Macaques after Autologous Hematopoietic Stem Cell Transplant , 2014, PLoS pathogens.

[29]  D. Schadendorf,et al.  Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation. , 2014, The New England journal of medicine.

[30]  S. Furlan,et al.  CD8-predominant T-cell CNS infiltration accompanies GVHD in primates and is improved with immunoprophylaxis. , 2014, Blood.

[31]  R. Schinazi,et al.  Analysis of Multiply Spliced Transcripts in Lymphoid Tissue Reservoirs of Rhesus Macaques Infected with RT-SHIV during HAART , 2014, PloS one.

[32]  Hannah W. Miller,et al.  Robust suppression of env‐SHIV viremia in Macaca nemestrina by 3‐drug ART is independent of timing of initiation during chronic infection , 2013, Journal of medical primatology.

[33]  A. Krishnan,et al.  Plasma Viremia and Cellular HIV-1 DNA Persist Despite Autologous Hematopoietic Stem Cell Transplantation for HIV-Related Lymphoma , 2013, Journal of acquired immune deficiency syndromes.

[34]  A. LaCasce,et al.  Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. , 2013, The Journal of infectious diseases.

[35]  R. Siliciano,et al.  Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies , 2013, PLoS pathogens.

[36]  Richard J. Jones,et al.  HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. , 2012, Blood.

[37]  A. Kirk,et al.  Evidence for Kidney Rejection After Combined Bone Marrow and Renal Transplantation Despite Ongoing Whole‐Blood Chimerism in Rhesus Macaques , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[38]  B. Blazar,et al.  Nonhuman Primate Transplant Models Finally Evolve: Detailed Immunogenetic Analysis Creates New Models and Strengthens the Old , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[39]  S. Lank,et al.  Immunogenetic Management Software: a new tool for visualization and analysis of complex immunogenetic datasets , 2012, Immunogenetics.

[40]  Shingo Iwami,et al.  Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy. , 2012, Virology.

[41]  K. Reimann,et al.  CD40 Blockade Combines with CTLA4Ig and Sirolimus to Produce Mixed Chimerism in an MHC‐Defined Rhesus Macaque Transplant Model , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[42]  E. Thiel,et al.  Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation. , 2011, Blood.

[43]  J. Zaia,et al.  Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years , 2011, Clinical and experimental immunology.

[44]  Brigitte E. Sanders-Beer,et al.  Clinical monitoring and correlates of nephropathy in SIV-infected macaques during high-dose antiretroviral therapy , 2011, AIDS research and therapy.

[45]  E. Thiel,et al.  Allogeneic transplantation of CCR5-deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2. , 2011, AIDS.

[46]  E. Elder,et al.  GVHD after haploidentical transplantation: a novel, MHC-defined rhesus macaque model identifies CD28- CD8+ T cells as a reservoir of breakthrough T-cell proliferation during costimulation blockade and sirolimus-based immunosuppression. , 2010, Blood.

[47]  R. Wiseman,et al.  An MHC‐Defined Primate Model Reveals Significant Rejection of Bone Marrow After Mixed Chimerism Induction Despite Full MHC Matching , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[48]  E. Thiel,et al.  Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. , 2009, The New England journal of medicine.

[49]  Shiu-Lok Hu,et al.  Pathogenic infection of Macaca nemestrina with a CCR5-tropic subtype-C simian-human immunodeficiency virus , 2009, Retrovirology.

[50]  H. Lazarus,et al.  Donor lymphocyte infusions: the long and winding road: how should it be traveled? , 2008, Bone Marrow Transplantation.

[51]  Vicki C. Ashley,et al.  Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia , 2008, Journal of Virology.

[52]  Allen R. Chen,et al.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[53]  J. Overbaugh,et al.  Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus challenge , 2007, Journal of medical primatology.

[54]  D. O’Connor,et al.  Simian Immunodeficiency Virus SIVmac239 Infection of Major Histocompatibility Complex-Identical Cynomolgus Macaques from Mauritius , 2006, Journal of Virology.

[55]  H. McClure,et al.  Molecularly Cloned SHIV-1157ipd3N4: a Highly Replication- Competent, Mucosally Transmissible R5 Simian-Human Immunodeficiency Virus Encoding HIV Clade C env , 2006, Journal of Virology.

[56]  R. Bontrop,et al.  Microsatellite typing of the rhesus macaque MHC region , 2005, Immunogenetics.

[57]  Olivia Keiser,et al.  Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. , 2005, Journal of the National Cancer Institute.

[58]  N. Pedersen,et al.  Biological Effects of Short-Term or Prolonged Administration of 9-[2-(Phosphonomethoxy)Propyl]Adenine (Tenofovir) to Newborn and Infant Rhesus Macaques , 2004, Antimicrobial Agents and Chemotherapy.

[59]  P. Guénel,et al.  Acute myeloid leukaemia in human immunodeficiency virus‐infected adults: epidemiology, treatment feasibility and outcome , 2001, British journal of haematology.

[60]  H. McClure,et al.  Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems. , 2000, AIDS research and human retroviruses.

[61]  R. Lempicki,et al.  HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Steven M. Wolinsky,et al.  The role of a mutant CCR5 allele in HIV–1 transmission and disease progression , 1996, Nature Medicine.

[63]  J J Goedert,et al.  Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.

[64]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[65]  G. Heidecker,et al.  Protection of macaques against simian AIDS by immunization with a recombinant vaccinia virus expressing the envelope glycoproteins of simian type D retrovirus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[66]  J. Steckbeck,et al.  Dissecting the humoral immune response to simian immunodeficiency virus , 2006, Immunologic research.